Gevo, Inc. (NASDAQ:GEVO - Get Free Report) was up 3.8% during mid-day trading on Wednesday . The company traded as high as $2.23 and last traded at $2.17. Approximately 1,822,485 shares traded hands during trading, a decline of 84% from the average daily volume of 11,602,997 shares. The stock had previously closed at $2.09.
Analyst Upgrades and Downgrades
Several research firms have recently weighed in on GEVO. HC Wainwright reaffirmed a "buy" rating and issued a $14.00 target price on shares of Gevo in a report on Wednesday, November 13th. UBS Group boosted their price target on shares of Gevo from $0.85 to $3.25 and gave the company a "neutral" rating in a research report on Tuesday, October 22nd.
View Our Latest Research Report on Gevo
Gevo Trading Up 5.7 %
The company has a debt-to-equity ratio of 0.13, a quick ratio of 8.05 and a current ratio of 8.25. The stock has a market cap of $529.09 million, a P/E ratio of -6.50 and a beta of 2.77. The company has a 50-day simple moving average of $1.75 and a 200-day simple moving average of $1.42.
Insider Activity
In related news, insider Paul D. Bloom sold 16,000 shares of the firm's stock in a transaction that occurred on Thursday, October 17th. The shares were sold at an average price of $3.06, for a total value of $48,960.00. Following the completion of the sale, the insider now owns 947,882 shares of the company's stock, valued at $2,900,518.92. This trade represents a 1.66 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider Andrew Shafer sold 26,911 shares of the business's stock in a transaction that occurred on Tuesday, November 5th. The stock was sold at an average price of $2.37, for a total transaction of $63,779.07. Following the completion of the transaction, the insider now owns 332,430 shares of the company's stock, valued at $787,859.10. This trade represents a 7.49 % decrease in their position. The disclosure for this sale can be found here. 4.00% of the stock is currently owned by corporate insiders.
Hedge Funds Weigh In On Gevo
Several large investors have recently made changes to their positions in the company. Signal Advisors Wealth LLC bought a new stake in Gevo during the 4th quarter worth about $34,000. Lauterbach Financial Advisors LLC acquired a new stake in shares of Gevo during the 3rd quarter worth approximately $29,000. International Assets Investment Management LLC bought a new stake in shares of Gevo during the fourth quarter worth approximately $59,000. XTX Topco Ltd lifted its holdings in Gevo by 61.8% in the second quarter. XTX Topco Ltd now owns 133,674 shares of the energy company's stock valued at $74,000 after buying an additional 51,057 shares during the period. Finally, Financial Advocates Investment Management bought a new position in Gevo in the third quarter valued at approximately $114,000. Institutional investors and hedge funds own 35.17% of the company's stock.
About Gevo
(
Get Free Report)
Gevo, Inc operates as a carbon abatement company. It operates through three segments: Gevo, Agri-Energy, and Renewable Natural Gas. The company focuses on transforming renewable energy into energy-dense liquid hydrocarbons that can be used as renewable fuels. It offers renewable gasoline and diesel, isobutanol, sustainable aviation fuel, renewable natural gas, isobutylene, ethanol, and animal feed and protein.
Further Reading
Before you consider Gevo, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Gevo wasn't on the list.
While Gevo currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.